Key statistics
As of last trade Bio-Techne Corp (TE1:DUS) traded at 70.00, -8.50% below its 52-week high of 76.50, set on May 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 70.00 |
---|---|
High | 70.00 |
Low | 70.00 |
Bid | 70.50 |
Offer | 72.00 |
Previous close | 69.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 158.89m |
Free float | 157.24m |
P/E (TTM) | 80.80 |
Market cap | 12.07bn USD |
EPS (TTM) | 0.9402 USD |
Annual div (ADY) | 0.2986 EUR |
---|---|
Annual div yield (ADY) | 0.43% |
Div ex-date | Nov 08 2024 |
Div pay-date | Nov 22 2024 |
Data delayed at least 15 minutes, as of Nov 11 2024 07:11 GMT.
More ▼
Press releases
- BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
- BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
- ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy
- BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
- LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
- BIO-TECHNE DECLARES DIVIDEND
- BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
- ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics
- BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS
- ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences
More ▼